Troy A. Ignelzi

Insider Reports History

Location
Plymouth, MI
Signature
/s/ Peter Slover, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Troy A. Ignelzi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Karuna Therapeutics, Inc. Chief Financial Officer Option (right to buy) 93,226 $10,301,473 $110.50 22 Aug 2023 Direct
Karuna Therapeutics, Inc. Chief Financial Officer Common Stock 30,487 $9,658,586 $316.81 22 Aug 2023 Direct
Rapport Therapeutics, Inc. Chief Financial Officer Common Stock 10,000 $99,800 $9.98 13 Mar 2025 Direct
Rapport Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 142,000 03 Feb 2025 Direct
Contineum Therapeutics, Inc. Director Stock Option (right to buy) 14,750 26 Jun 2025 Direct
CinCor Pharma, Inc. Director Stock Option (Right to Buy) 0 $8.34 24 Feb 2023 Direct

Insider Reports Filed by Troy A. Ignelzi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTNM Contineum Therapeutics, Inc. 26 Jun 2025 1 $0 4 Director 26 Jun 2025, 17:44
RAPP Rapport Therapeutics, Inc. 12 Mar 2025 2 +$100,988 4 Chief Financial Officer 13 Mar 2025, 17:13
RAPP Rapport Therapeutics, Inc. 03 Feb 2025 1 $0 4 Chief Financial Officer 04 Feb 2025, 17:30
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 1 $0 4 Chief Financial Officer 10 Jun 2024, 19:35
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 0 $0 3 Chief Financial Officer 06 Jun 2024, 18:46
CTNM Contineum Therapeutics, Inc. 24 May 2024 1 $0 4 Director 29 May 2024, 17:56
CTNM Contineum Therapeutics, Inc. 20 May 2024 0 $0 3 Director 20 May 2024, 19:03
CTNM Contineum Therapeutics, Inc. 20 May 2024 1 $0 4 Director 20 May 2024, 19:00
/report/000095017023044413-ignelzi-troy-a-2023-08-22 Karuna Therapeutics, Inc. 22 Aug 2023 6 -$248,883 4 Chief Financial Officer 24 Aug 2023, 17:49
/report/000095017023024286-ignelzi-troy-a-2023-05-23 Karuna Therapeutics, Inc. 23 May 2023 8 -$1,927,862 4 Chief Financial Officer 25 May 2023, 17:00
/report/000120919123012898-ignelzi-troy-a-2023-02-24 CinCor Pharma, Inc. 24 Feb 2023 2 $0 4 Director 24 Feb 2023, 17:40
/report/000159396823000345-ignelzi-troy-a-2023-02-21 Karuna Therapeutics, Inc. 21 Feb 2023 3 -$1,084,860 4 Chief Financial Officer 23 Feb 2023, 15:37
/report/000159396823000304-ignelzi-troy-a-2023-02-09 Karuna Therapeutics, Inc. 09 Feb 2023 2 $0 4 Chief Financial Officer 13 Feb 2023, 15:39
/report/000159396823000170-ignelzi-troy-a-2023-01-17 Karuna Therapeutics, Inc. 17 Jan 2023 6 -$195,224 4 Chief Financial Officer 19 Jan 2023, 15:45
/report/000159396822001741-ignelzi-troy-a-2022-12-16 Karuna Therapeutics, Inc. 16 Dec 2022 6 +$109,176 4 Chief Financial Officer 19 Dec 2022, 15:24
/report/000159396822001609-ignelzi-troy-a-2022-11-15 Karuna Therapeutics, Inc. 15 Nov 2022 3 -$3,574,725 4 Chief Financial Officer 17 Nov 2022, 16:08
/report/000159396822001490-ignelzi-troy-a-2022-09-30 Karuna Therapeutics, Inc. 30 Sep 2022 8 -$3,444,117 4 Chief Financial Officer 04 Oct 2022, 19:25
/report/000159396822001335-ignelzi-troy-a-2022-08-09 Karuna Therapeutics, Inc. 09 Aug 2022 3 -$3,607,395 4 Chief Financial Officer 11 Aug 2022, 17:17
/report/000159396822000886-ignelzi-troy-a-2022-04-19 Karuna Therapeutics, Inc. 19 Apr 2022 9 -$517,941 4 Chief Financial Officer 21 Apr 2022, 19:04
/report/000159396822000496-ignelzi-troy-a-2022-02-15 Karuna Therapeutics, Inc. 15 Feb 2022 4 -$152,910 4 Chief Financial Officer 17 Feb 2022, 16:21
/report/000120919122002286-ignelzi-troy-a-2022-01-06 CinCor Pharma, Inc. 06 Jan 2022 0 $0 3 Director 06 Jan 2022, 19:57
/report/000159396821002566-ignelzi-troy-a-2021-12-21 Karuna Therapeutics, Inc. 21 Dec 2021 4 +$64,124 4 Chief Financial Officer 22 Dec 2021, 15:42
/report/000159396821002380-ignelzi-troy-a-2021-11-08 Karuna Therapeutics, Inc. 08 Nov 2021 3 -$1,932,120 4 Chief Financial Officer 10 Nov 2021, 15:08
/report/000159396821002107-ignelzi-troy-a-2021-09-08 Karuna Therapeutics, Inc. 08 Sep 2021 12 -$1,081,846 4 Chief Financial Officer 10 Sep 2021, 16:58
/report/000159396821002003-ignelzi-troy-a-2021-08-20 Karuna Therapeutics, Inc. 20 Aug 2021 2 +$46,000 4 Chief Financial Officer 23 Aug 2021, 16:16
/report/000159396821001633-ignelzi-troy-a-2021-06-14 Karuna Therapeutics, Inc. 14 Jun 2021 9 -$423,268 4 Chief Financial Officer 16 Jun 2021, 19:01
/report/000159396821001292-ignelzi-troy-a-2021-05-10 Karuna Therapeutics, Inc. 10 May 2021 6 -$728,250 4 Chief Financial Officer 12 May 2021, 17:28